Navigation Links
Daiichi Sankyo, Inc. Announces Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology
Date:12/2/2008

on Sunday, December 7, 2008.
  • Study of Coagulation and Platelets Response in an Open Label Randomized Non Treatment and Active Controlled (Dalteparin, Ximelagatran and DU-176b) in 4 Groups of Elderly Healthy Subjects (Abstract 3026), Professor Michel Meyer Samama, Biomnis, Ivry-sur-Seine cedex, France, Satoshi Kunitada, Daiichi Sankyo Pharma Development, Edison, New Jersey, A. Oursin, Biomnis, Ivry-sur-Seine cedex, France, Francois Depasse, Biomnis, Ivry-sur-Seine cedex, France and Nazneen Haque, Daiichi Sankyo Development Ltd., Gerald Cross, Buckinghamshire, United Kingdom. This will be a poster presentation on Monday, December 8, 2008.

    • To arrange an interview with Francis Plat, MD, vice president, clinical development at Daiichi Sankyo Pharma Development, or Jeffrey Weitz, MD, FACP, FRCP, Professor of Medicine and Biochemistry, McMaster University and Director, Henderson Research Centre, Hamilton, Ontario at the 2008 ASH Meeting in San Francisco, please contact Kim Wix, Daiichi Sankyo, at 973-695-8338 (office) 908-656-5447 (mobile) or Catherine Falcetti, MS&L, at 212-468-4337 (office) or 646-246-1843 (mobile).

    About DU-176b

    DU-176b is an oral anticoagulant that directly inhibits Factor Xa, a clotting factor in the blood. Daiichi Sankyo is developing DU-176b as a potential new treatment for the prevention of both arterial and venous thromboembolism.

    About Daiichi Sankyo, Inc.

    A global pharma innovator, Daiichi Sankyo Co., Ltd., was established in 2005 through the merger of two leading Japanese pharmaceutical companies. This integration created a more robust organization that allows for continuous development of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research and development is cardiovascular disease, includ
    '/>"/>

    SOURCE Daiichi Sankyo, Inc.
    Copyright©2008 PR Newswire.
    All rights reserved

    3

    GOOD

    Page: 1 2 3

    Related medicine news :

    1. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
    2. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
    3. Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
    4. Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
    5. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
    6. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
    7. In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia
    8. EMS Magazine Announces Top Innovation Awards for 2008
    9. Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
    10. Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
    11. Transition Therapeutics Announces Dates for Upcoming Corporate Events

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/1/2009)...iel Jordan Fiddle Foundation, a national autism or...or, and support programs and services for adolesce...), has released a free informational brochure enti...o Recognize The Signs and Basic First Aid When You... (PRWEB) December 1, 2009 -- Statistics show that ...
    (Date:12/1/2009)... Cell Therapeutics, Inc...tation at the 21st Annual Piper Jaffray Health Car...Eastern Time will be webcast live at www.cellther...place in Holmes 1 at the New York Palace Hotel, an...entation. , , Piper Jaffray ...
    (Date:12/1/2009)...al magnetic resonance imaging (fMRI) to evaluate b...d to lead as children incur permanent brain injury...eeting of the Radiological Society of North Americ...n of the brain is spared from lead exposure," said...g scientist at Cincinnati Children,s Hospital Medi...
    (Date:11/30/2009)...ast Fertility is attempting to dispel the notion t...and send patients home pregnant with multiples. W...ent, their priority is health and safety. In addi...hs can put on a country’s healthcare system...., 2009 -- Many patients and doctors in the U.K. wo...
    (Date:11/30/2009)...wswire/ -- Low-dose radiation from annual mammogra...omen with genetic or familial predisposition to br...at the annual meeting of the Radiological Society ... risk for breast cancer, screening is very importa...nsidering mammography for screening young women, p...
    Breaking Medicine News(10 mins):Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 4Health News:Childhood lead exposure causes permanent brain damage 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 3Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 2Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 3
    ..., Lower Drug Costs for America,s Seniors, WASHING...of Inspector General (OIG) finding that in Medicar...f the time when generic,substitutes were available...costs for America,s seniors, said the,Pharmaceutic...
    ...EC-D(R) 12 HOUR(R) to be Available in Stores Natio... FT. WASHINGTON, Pa., Nov. 16 McNeil Consumer,Hea... today that it,received approval from the U.S. Foo...(R) relieves symptoms due to,perennial and seasona...
    ...., Nov. 16 The National Football,League Alliance ... program,focusing on heart health screenings for f... Health Broward General Medical Center.,Partnering... 30 NFL alumni chapter presidents and board member...
    ... Kensey Nash Corporation,(Nasdaq: KNSY ) will pre...Conference at The Pierre Hotel in New York, New Yo...fmann, Kensey Nash,s President & CEO, will deliver...//www.kenseynash.com ) beginning at 12:00 p.m. (ET...
    ...atisfy all requirements for continued listing and ...er 31, 2007, MILWAUKEE, Nov. 16 Merge Technologi... MRGE ; TSX: MRG) (the,"Company") today announced ... timely file its Quarterly Report on Form 10-Q,for...
    ...ov. 16 Keck Graduate Institute,(KGI), in partners...f more,two dozen industry speakers for the "Next G...lp women managers advance in the life sciences,ind...xecutives in the life,science industry for this fi...
    Other Medicine News:Health News:New OIG Report Confirms Part D Plans Are Driving Generic Utilization 2Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 2Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 3Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 4Health News:Broward Health and ProHeart MD Kick Off NFL Alumni Health Program 2Health News:Merge Technologies Receives Expected Additional NASDAQ Notification 2Health News:Merge Technologies Receives Expected Additional NASDAQ Notification 3Health News:KGI and Smith College Announce Speakers for Women Leadership Forum in Bioscience 2Health News:KGI and Smith College Announce Speakers for Women Leadership Forum in Bioscience 3
    (Date:11/30/2009)... , EAST ALTON, Ill., Nov. 30 Th... committee dedicated to representing thousands of ... (Yasmin), the popular birth control pill manufact...The U.S. Judicial Panel on Multidistrict Litigatio...h control pill lawsuits be consolidated and centra...
    (Date:11/30/2009)... , CHICAGO, Nov. 30 MedPro Im...ltrasound solutions, will showcase leading ultraso...Logiq I and Siemens X300 Premium Edition during th... North America (RSNA) conference, being held in Ch...sed MedPro Imaging markets ultrasound products and...
    (Date:11/30/2009)... , ATLANTA, Nov. 30 Amoena ...ery breast care products, is sponsoring the 4th An...the first time, Amoena will honor survivors and th... awarding a cabin for the one with the most inspir...t, Amoena wants to hear about young mothers who br...
    Breaking Medicine Technology:Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2Even Light Smoking Affects Young Adults Arteries 60232 1Even Light Smoking Affects Young Adults Arteries 60232 2Cranberries Provide Eight Hour Health Protection 60228 1Cranberries Provide Eight Hour Health Protection 60228 2Cranberries Provide Eight Hour Health Protection 60228 3Morphotek 28R 29 Inc Announces a Licensing Deal With Centocor Ortho Biotech Inc for Exclusive Development and Commercialization Rights for a Therap 60224 1Morphotek 28R 29 Inc Announces a Licensing Deal With Centocor Ortho Biotech Inc for Exclusive Development and Commercialization Rights for a Therap 60224 2
    Cardiology at a Glance for PDA
    ...moCor Mx Central Blood Pressure Monitoring System ...em by providing continuous, real-time derivation o...scular parameters are sampled every 5 seconds, and... Systolic, Diastolic, and Pulse Pressures , A...
    Genetic Systems HIV-1/HIV-2 PLUS O EIA (detects Ab to HIV-1 (M+O) and HIV-2)
    Shandon Humidity Chamber
    Medicine Products: